Skip to Content

KADIAN 200 mg (Morphine Sulfate Extended Release 200 mg)

Pill with imprint KADIAN 200 mg is Brown, Capsule-shape and has been identified as Morphine Sulfate Extended Release 200 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 200 mg

Morphine sulfate extended release 200 mg KADIAN 200 mg

Morphine Sulfate Extended Release

Imprint
KADIAN 200 mg
Strength
200 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis
National Drug Code (NDC)
00228-3508

Get help with Imprint Code FAQs.

Related Images for "KADIAN 200 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.